Viewing Study NCT01342757


Ignite Creation Date: 2025-12-24 @ 6:36 PM
Ignite Modification Date: 2026-05-22 @ 6:57 PM
Study NCT ID: NCT01342757
Status: COMPLETED
Last Update Posted: 2018-01-29
First Post: 2011-04-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Glioblastoma View
None Depression View
None Recurrent Adult Brain Tumor View
Keywords: